Pulmonary vascular disease

Pulmonary vascular disease

Prothrombotic state in patients with stable COPD: an observational study
Christos Kyriakopoulos, Christos Chronis, Evaggelia Papapetrou, Athina Tatsioni, Konstantina Gartzonika, Christina Tsaousi, Athena Gogali, Christos Katsanos, Aikaterini Vaggeli, Charikleia Tselepi, Georgios Daskalopoulos, Stavros Konstantopoulos, Konstantinos Kostikas, Athanasios Konstantinidis

ERJ Open Research Oct 2021, 7 (4) 00297-2021; DOI: 10.1183/23120541.00297-2021
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension
Catherine E. Simpson, Megan Griffiths, Jun Yang, Melanie K. Nies, R. Dhananjay Vaidya, Stephanie Brandal, Lisa J. Martin, Michael W. Pauciulo, Katie A. Lutz, Anna W. Coleman, Eric D. Austin, D. Dunbar Ivy, William C. Nichols, Allen D. Everett, Paul M. Hassoun, Rachel L. Damico

ERJ Open Research Oct 2021, 7 (4) 00378-2021; DOI: 10.1183/23120541.00378-2021
Effect of a day-trip to altitude (2500 m) on exercise performance in pulmonary hypertension: randomised crossover trial
Simon R. Schneider, Laura C. Mayer, Mona Lichtblau, Charlotte Berlier, Esther I. Schwarz, Stéphanie Saxer, Lu Tan, Michael Furian, Konrad E. Bloch, Silvia Ulrich

ERJ Open Research Oct 2021, 7 (4) 00314-2021; DOI: 10.1183/23120541.00314-2021
Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset
Joseph Newman, Iryna Boubriak, David Jenkins, Choo Ng, Alessandro Ruggiero, Nicholas Screaton, John Cannon, Mark Toshner

ERJ Open Research Oct 2021, 7 (4) 00431-2021; DOI: 10.1183/23120541.00431-2021
Improvement in exercise capacity after a modified Potts shunt in an adult patient with pulmonary arterial hypertension
Petr Symersky, Samara M.A. Jansen, Suzanne K. Kamminga, Lilian J. Meijboom, Erik J. Lust, Pirooz Eghtesady, Robert M. Grady, Harm J. Bogaard

ERJ Open Research Oct 2021, 7 (4) 00287-2021; DOI: 10.1183/23120541.00287-2021
Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study
Suqiao Yang, Yuanhua Yang, Yixiao Zhang, Tuguang Kuang, Juanni Gong, Jifeng Li, Yidan Li, Jianfeng Wang, Xiaojuan Guo, Ran Miao

ERJ Open Research Jul 2021, 7 (3) 00082-2021; DOI: 10.1183/23120541.00082-2021
A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension
Gudula J.A.M. Boon, Wilbert B. van den Hout, Stefano Barco, Harm Jan Bogaard, Marion Delcroix, Menno V. Huisman, Stavros V. Konstantinides, Lilian J. Meijboom, Esther J. Nossent, Petr Symersky, Anton Vonk Noordegraaf, Frederikus A. Klok

ERJ Open Research Jul 2021, 7 (3) 00719-2020; DOI: 10.1183/23120541.00719-2020
Impairment of skeletal muscle oxygen extraction and cardiac output are matched in precapillary pulmonary hypertension
Harrison Stubbs, Colin Church, Martin Johnson, Stephen Thomson

ERJ Open Research Jul 2021, 7 (3) 00449-2021; DOI: 10.1183/23120541.00449-2021
Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study
Chinthaka B. Samaranayake, Gregory Keir, Simon A.A. Slader, Tommy Tseng, Khoa Tran, James Anderson, Andrew McCann, Colm McCabe, John W. Upham

ERJ Open Research Jul 2021, 7 (3) 00379-2021; DOI: 10.1183/23120541.00379-2021
Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study
Laurence Halimi, Carey M. Suehs, Gregory Marin, Clement Boissin, Anne-Sophie Gamez, Isabelle Vachier, Nicolas Molinari, Arnaud Bourdin

ERJ Open Research Jul 2021, 7 (3) 00617-2020; DOI: 10.1183/23120541.00617-2020

Main menu

User menu

Search

Pulmonary vascular disease

Pages

Contact us